Skip to main content
Federal Lobbying Data · Senate LDA Filings · Updated Quarterly
LobbySpend

AstraZeneca

Pharmaceutical & Health Products · Lobbying Client

C
Influence Score
58/100
Moderate Influence
$17.9M
Total Lobby Spend
5
Policy Issues
12
Lobbyists
4
Revolving Door

AstraZeneca reported $17.9 million in federal lobbying expenditures (2020-2024) as disclosed in Senate LDA filings. The organization's lobbying activity spans 5 policy areas, with primary focus on Health Issues, Pharmacy, Medical/Disease Research. This data is drawn from quarterly disclosure reports filed with the Secretary of the Senate under the Lobbying Disclosure Act of 1995. All lobbying disclosure data sourced from Senate lobbying disclosure filings filed under the Lobbying Disclosure Act.

Annual Lobbying Spend

Policy Issues

Government Entities Contacted

Dept of Housing & Urban Development
Environmental Protection Agency
Federal Aviation Administration
Dept of Energy
Dept of Justice
Federal Trade Commission
Dept of State

Recent Filings

PeriodRegistrantIssuesLobbyistsAmount
2024 Oct-DecCovington & Burling
PHAMEDHCR
1$879K
2024 Jul-SepHogan Lovells
HCRTAXMED
4$1.1M
2024 Apr-JunWilliams & Jensen
HCRPHAMED+1
4$1.0M
2024 Jan-MarTarplin, Downs & Young
TAXMED
3$1.2M
2023 Oct-DecFranklin Square Group
TAXPHAHCR+2
1$919K
2023 Jul-SepVan Scoyoc Associates
TAXHCRMED+2
3$765K
2023 Apr-JunDLA Piper
HCRMEDTAX
2$767K
2023 Jan-MarCornerstone Government Affairs
TAXGOV
4$739K

AstraZeneca Lobbying FAQ

AstraZeneca has spent $17.9M on federal lobbying across 5 policy areas. This includes spending on registered lobbyists and direct government contacts.

AstraZeneca lobbies on 5 policy issues, including Health Issues, Pharmacy, Medical/Disease Research, Taxation. These disclosures are filed quarterly with the Senate Office of Public Records.

AstraZeneca has an Influence Score of 58/100 (Grade C). This proprietary score is based on total lobby spend (40%), policy issue breadth (30%), and revolving door connections (30%).

AstraZeneca employs 12 registered lobbyists, of whom 4 have revolving door connections, meaning they previously held government positions before becoming lobbyists.

AstraZeneca has contacted 7 government entities as part of their lobbying activities, including Dept of Housing & Urban Development, Environmental Protection Agency, Federal Aviation Administration.

Sources: Senate Office of Public Records (LDA), OpenSecrets.org
Last updated:

Lobbying data is sourced from quarterly Lobbying Disclosure Act (LDA) filings with the Senate Office of Public Records. Influence Scores combine total spend (40%), issue breadth (30%), and revolving door connections (30%). Filings may be amended after initial submission.